Literature DB >> 26874151

Prevalence of visual hallucinations in a national low vision client population.

Keith D Gordon1.   

Abstract

PURPOSE: To evaluate the prevalence of visual hallucinations (Charles Bonnet syndrome) in a national population undergoing vision rehabilitation. STUDY
DESIGN: Cross-sectional survey. PARTICIPANTS: Participants were 2565 new clients older than 40 years attending a Canadian National Institute for the Blind (CNIB) vision rehabilitation clinic.
METHODS: Participants were asked the following question: "Many people who come to CNIB tell us that they see things they know are not there. Some see patterns or shapes. Others see images of people or animals. Have you ever experienced this?" Responses were cross-tabulated on the basis of age, sex, eye disease, visual acuity, and whether the clients lived alone. Multivariable logistic regression was used to analyze the responses.
RESULTS: Overall, 18.8% of people surveyed indicated that they had experienced hallucinations. In the multivariable model, females showed higher odds of hallucinations than males did (odds ratio [OR] 1.32, 95% CI 1.06-1.64, p = 0.02). Clients with greater vision loss had higher chances of experiencing hallucinations than those with the lowest level of vision loss (OR 1.49, 95% CI 1.19-1.88, p = 0.0005). There was no significant difference in the chances of experiencing hallucinations between people with age-related macular degeneration, diabetic retinopathy, and glaucoma, or in older versus younger respondents. People who did not live alone had higher chances of experiencing hallucinations than those who lived alone (OR 1.54, 95% CI 1.19-1.98, p = 0.0009).
CONCLUSIONS: Visual hallucinations are experienced by approximately 1 in 5 patients with vision loss caused by any eye disease, warranting greater awareness of the phenomenon among all vision health professionals and their patients.
Copyright © 2015 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26874151     DOI: 10.1016/j.jcjo.2015.10.006

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  3 in total

1.  A low dose of risperidone resolved Charles Bonnet syndrome after an unsuccessful trial of quetiapine: a case report.

Authors:  Sultan H Alamri
Journal:  Neuropsychiatr Dis Treat       Date:  2018-03-20       Impact factor: 2.570

2.  Vivid Visual Hallucinations in Visually Impaired: Charles Bonnet Syndrome - An Analog to "Phantom-Limb Phenomenon".

Authors:  Ananya Das; Gutti Nagendra Babu; Ankit Gupta; Vikas Kanaujia; Vimal Kumar Paliwal
Journal:  Ann Indian Acad Neurol       Date:  2020-06-05       Impact factor: 1.383

3.  Assessing differential effects of single and accelerated low-frequency rTMS to the visual cortex on GABA and glutamate concentrations.

Authors:  Sara A Rafique; Jennifer K E Steeves
Journal:  Brain Behav       Date:  2020-09-23       Impact factor: 2.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.